[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-OSTX":3,"homepage-market-summary":31,"stock-news-OSTX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"OSTX","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"OS Therapies Incorporated","NYSE American",null,"PHARMACEUTICAL PREPARATIONS","OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.","5","Rockville, MD",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},1.55,1.5,1.5653,1.464,1.49,0.06,4.03,569552.234031,1906,1.5271,2.25,1.15,595732.9876665737,36.4,548,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},7,[176,182,188,193,199,204,210],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"OSTX Stock Holds Tight Range As Traders Probe Weak Financials - StocksToTrade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihAFBVV95cUxPdERHS1dqLXJIMmFLSEFmdjZkU3R5RW9tRlpOdE9zcS12MjZpUUZvQmtXMmxnbVhKXy04dzNDUkFVVXpid24wcnBVNDJCQU5INXB0YmRGRWE0V19CSVpyazZjQnAxY3g3ZFlBUFNzZ3hmMndTNDAwLUlOM0dRZFJ2YVVpYTI?oc=5","Tue, 06 Oct 2026 13:17:00 GMT","OSTX Stock Holds Tight Range As Traders Probe Weak Financials StocksToTrade","StocksToTrade",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"OS Therapies has received over $3M in tax refunds and accrued over $7M in research tax credits. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPZ3BkOVpobHRiRTRSM0xKamIxdFR4a09zVmV0MzZZM1ZoU0NFTWZxWnhUeFoxUzRTN2RLckdnV1J2ZTNEVjRqa0hfMmtDRkVXVmtaM21PM0F5UkpUQzdvNGNtSFpjQmxaZzhveDF6OFk3aHBBdDNGV21XTlVQSXJDa1FXWlNrWkNZdlJadW4zaDdrVHk2U1I3b1YxRjU5OEg0NTB2Q2VJbTNZUnBvbVh5UENIbWt2cFY5V3Jj?oc=5","Thu, 01 Oct 2026 12:30:00 GMT","OS Therapies has received over $3M in tax refunds and accrued over $7M in research tax credits. Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":187},"72.7% of treated patients survived three years, versus 45.8% in historical comparisons. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxQcTVEQ3B1clBmOHpLN0RJc2FaNlJWLThfcExNdWUtOWwyMlZjU0lURUNZSUV4T1VfVEdHX0FJOS0xUjJKT0lhajdlc2tULW4wYVRwMGlvbzZobER6WDFHZHZKdl82NU04eDJfRkdzbGFIeEgwM0g5WF9lcWlMWS1WZVdQc2t4czdoVW9CX1ZnTG91UXlfLUQxckVRWDBwdkx0STkzYUlsUlRtaENxcWp3V3dlZFlPMVNmdzkw?oc=5","Tue, 06 Oct 2026 12:30:00 GMT","72.7% of treated patients survived three years, versus 45.8% in historical comparisons. Stock Titan",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxQSEhXMmNMRGpJczNhOTFpWnV0bV9nYnZsUDZ0bFNFNzVndTJjMTRpMWxvVlZOQ0NaR2hvak90Vmp1MFhIVWk2YkU4dG9USkowRWN0ZHdIVGo2aGtfek5rdm5VdWg0ckI5eTVmTTlVN290Rmp5OUlEMldUZGl0YnNrcjN3QjhtYzE5YnFhMHFZUXdBYVNzdkxEa3dBcTVUQl9xQk9hR0NzNkFKMkZRZ09GM1lDb2g2NTBYZk5MdGJEV3ZNdm1CUl9NZ2RyYWtHOU1nd2NKbEh3?oc=5","Tue, 06 Oct 2026 17:19:52 GMT","OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment Benzinga","Benzinga",{"title":200,"link":201,"pubDate":202,"description":203,"source":187},"A dog cancer treatment could launch in the U.S. in 2027, OS Therapies hopes - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOQXZrcm80RGU5ZzFqU1JtNzh1b1BYM2dPTlBCVUd1eHdXck56MDRxRUhwZ2lJRmdkQ3ROMFBIc2xteGN5UzM5YXoyTkxfOWpMSExkVkdiMjUzb2xhUzdjelB5NEd2T1pJYVNoWXNCSzdvT2FlM0kyc2l6dy1VZzYwRUlzTVhxVmxFSlVaRkpMWVVuLXZmeF9HNEF5WVo2cTNUZEl2RW1HM0FsUEpXejUtaVFqMG9JcXczZENqRQ?oc=5","Wed, 07 Oct 2026 12:30:00 GMT","A dog cancer treatment could launch in the U.S. in 2027, OS Therapies hopes Stock Titan",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"ZTG Should I Buy - Intellectia AI","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiXEFVX3lxTFBYSHRWN2JBZVEzSENOTGtvdGhlNE91eldMOUZMU1Y1N2NrMFBSdDFlbnl3ZHdlZWFNZWs1SG5ESWR5UXJsMzRHUF9mZ185ZGM2WUhTMHR0R0lDQjFV?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","ZTG Should I Buy Intellectia AI","Intellectia AI",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"OS Therapies bolsters leadership team amid commercialization push - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQclh4TTQ4cFNjeDh5dnV5UTlaNTZuVnRROFAwaXNSNE5BTEpremhPc1lsam5BVUxad3FXVUlvOXFPNmRCeUxQelRjNTBVTVVvdW5Ya21VeWI2UVpON0JWRkZnM3d4cjBuakFuV3dNdTY5Z1JuaWIwTVVKd0xVNkgxd29udmprSE1Zb2RqVWdHeVFaSG42R0kyMGNCS2Z0LXhFd2pUR01VNC04bnR3LWFZdmJwT0RVX3B5?oc=5","Mon, 05 Oct 2026 21:05:27 GMT","OS Therapies bolsters leadership team amid commercialization push TipRanks","TipRanks"]